MANNKIND CORP (MNKD) Stock Fundamental Analysis

NASDAQ:MNKD • US56400P7069

5.54 USD
-0.03 (-0.54%)
At close: Feb 24, 2026
5.6001 USD
+0.06 (+1.08%)
After Hours: 2/24/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

MNKD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. MNKD has an average financial health and profitability rating. MNKD is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • MNKD had positive earnings in the past year.
  • In the past year MNKD had a positive cash flow from operations.
  • MNKD had negative earnings in 4 of the past 5 years.
  • In multiple years MNKD reported negative operating cash flow during the last 5 years.
MNKD Yearly Net Income VS EBIT VS OCF VS FCFMNKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • MNKD has a better Return On Assets (5.81%) than 91.94% of its industry peers.
  • MNKD has a better Return On Invested Capital (18.48%) than 97.31% of its industry peers.
Industry RankSector Rank
ROA 5.81%
ROE N/A
ROIC 18.48%
ROA(3y)-8.37%
ROA(5y)-20.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNKD Yearly ROA, ROE, ROICMNKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

  • With an excellent Profit Margin value of 9.16%, MNKD belongs to the best of the industry, outperforming 90.59% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 27.48%, MNKD belongs to the top of the industry, outperforming 96.35% of the companies in the same industry.
  • MNKD's Gross Margin of 78.49% is amongst the best of the industry. MNKD outperforms 84.84% of its industry peers.
  • MNKD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.48%
PM (TTM) 9.16%
GM 78.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.44%
GM growth 5Y5.99%
MNKD Yearly Profit, Operating, Gross MarginsMNKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MNKD is creating value.
  • Compared to 1 year ago, MNKD has more shares outstanding
  • Compared to 5 years ago, MNKD has more shares outstanding
  • The debt/assets ratio for MNKD has been reduced compared to a year ago.
MNKD Yearly Shares OutstandingMNKD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
MNKD Yearly Total Debt VS Total AssetsMNKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -5.29, we must say that MNKD is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of MNKD (-5.29) is worse than 62.38% of its industry peers.
  • MNKD has a debt to FCF ratio of 8.39. This is a slightly negative value and a sign of low solvency as MNKD would need 8.39 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 8.39, MNKD belongs to the best of the industry, outperforming 90.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.39
Altman-Z -5.29
ROIC/WACC2.23
WACC8.27%
MNKD Yearly LT Debt VS Equity VS FCFMNKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • MNKD has a Current Ratio of 3.29. This indicates that MNKD is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of MNKD (3.29) is worse than 61.23% of its industry peers.
  • A Quick Ratio of 3.04 indicates that MNKD has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.04, MNKD is doing worse than 62.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.04
MNKD Yearly Current Assets VS Current LiabilitesMNKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 174.00% over the past year.
  • Looking at the last year, MNKD shows a quite strong growth in Revenue. The Revenue has grown by 17.44% in the last year.
  • The Revenue has been growing by 35.29% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)174%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%235%
Revenue 1Y (TTM)17.44%
Revenue growth 3Y55.86%
Revenue growth 5Y35.29%
Sales Q2Q%17.2%

3.2 Future

  • MNKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.41% yearly.
  • The Revenue is expected to grow by 18.67% on average over the next years. This is quite good.
EPS Next Y-2.25%
EPS Next 2Y4.45%
EPS Next 3Y43.65%
EPS Next 5Y52.41%
Revenue Next Year20.66%
Revenue Next 2Y23.07%
Revenue Next 3Y20.01%
Revenue Next 5Y18.67%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MNKD Yearly Revenue VS EstimatesMNKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
MNKD Yearly EPS VS EstimatesMNKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 39.57 indicates a quite expensive valuation of MNKD.
  • Compared to the rest of the industry, the Price/Earnings ratio of MNKD indicates a rather cheap valuation: MNKD is cheaper than 91.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.98, MNKD is valued a bit more expensive.
  • MNKD is valuated quite expensively with a Price/Forward Earnings ratio of 63.48.
  • MNKD's Price/Forward Earnings ratio is rather cheap when compared to the industry. MNKD is cheaper than 89.25% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of MNKD to the average of the S&P500 Index (28.01), we can say MNKD is valued expensively.
Industry RankSector Rank
PE 39.57
Fwd PE 63.48
MNKD Price Earnings VS Forward Price EarningsMNKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • MNKD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNKD is cheaper than 94.82% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, MNKD is valued cheaply inside the industry as 92.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 39.21
EV/EBITDA 17.29
MNKD Per share dataMNKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MNKD's earnings are expected to grow with 43.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.45%
EPS Next 3Y43.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MNKD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MANNKIND CORP

NASDAQ:MNKD (2/24/2026, 8:00:01 PM)

After market: 5.6001 +0.06 (+1.08%)

5.54

-0.03 (-0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)03-03
Inst Owners57.07%
Inst Owner Change3.48%
Ins Owners1.59%
Ins Owner Change1%
Market Cap1.70B
Revenue(TTM)313.79M
Net Income(TTM)28.75M
Analysts85.33
Price Target9.8 (76.9%)
Short Float %8.7%
Short Ratio7.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)53.26%
Min EPS beat(2)-100%
Max EPS beat(2)206.52%
EPS beat(4)1
Avg EPS beat(4)19.34%
Min EPS beat(4)-100%
Max EPS beat(4)206.52%
EPS beat(8)2
Avg EPS beat(8)-31.68%
EPS beat(12)5
Avg EPS beat(12)-2.87%
EPS beat(16)6
Avg EPS beat(16)-4.99%
Revenue beat(2)1
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)0.33%
Revenue beat(4)3
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)0.9%
Revenue beat(8)6
Avg Revenue beat(8)1.65%
Revenue beat(12)8
Avg Revenue beat(12)2.45%
Revenue beat(16)11
Avg Revenue beat(16)3.58%
PT rev (1m)0%
PT rev (3m)-7.36%
EPS NQ rev (1m)-23.56%
EPS NQ rev (3m)-51.87%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.43%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)7.56%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)5.67%
Valuation
Industry RankSector Rank
PE 39.57
Fwd PE 63.48
P/S 5.42
P/FCF 39.21
P/OCF 34.82
P/B N/A
P/tB N/A
EV/EBITDA 17.29
EPS(TTM)0.14
EY2.53%
EPS(NY)0.09
Fwd EY1.58%
FCF(TTM)0.14
FCFY2.55%
OCF(TTM)0.16
OCFY2.87%
SpS1.02
BVpS-0.15
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.81%
ROE N/A
ROCE 22.37%
ROIC 18.48%
ROICexc 48.2%
ROICexgc 50.4%
OM 27.48%
PM (TTM) 9.16%
GM 78.49%
FCFM 13.83%
ROA(3y)-8.37%
ROA(5y)-20.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.44%
GM growth 5Y5.99%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.39
Debt/EBITDA 3.59
Cap/Depr 64.99%
Cap/Sales 1.74%
Interest Coverage 9.12
Cash Conversion 51.63%
Profit Quality 150.89%
Current Ratio 3.29
Quick Ratio 3.04
Altman-Z -5.29
F-Score8
WACC8.27%
ROIC/WACC2.23
Cap/Depr(3y)397.13%
Cap/Depr(5y)337.1%
Cap/Sales(3y)10.78%
Cap/Sales(5y)10.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)174%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%235%
EPS Next Y-2.25%
EPS Next 2Y4.45%
EPS Next 3Y43.65%
EPS Next 5Y52.41%
Revenue 1Y (TTM)17.44%
Revenue growth 3Y55.86%
Revenue growth 5Y35.29%
Sales Q2Q%17.2%
Revenue Next Year20.66%
Revenue Next 2Y23.07%
Revenue Next 3Y20.01%
Revenue Next 5Y18.67%
EBIT growth 1Y48.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y237.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y386.62%
OCF growth 3YN/A
OCF growth 5YN/A

MANNKIND CORP / MNKD FAQ

What is the fundamental rating for MNKD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MNKD.


Can you provide the valuation status for MANNKIND CORP?

ChartMill assigns a valuation rating of 5 / 10 to MANNKIND CORP (MNKD). This can be considered as Fairly Valued.


Can you provide the profitability details for MANNKIND CORP?

MANNKIND CORP (MNKD) has a profitability rating of 5 / 10.


What are the PE and PB ratios of MANNKIND CORP (MNKD) stock?

The Price/Earnings (PE) ratio for MANNKIND CORP (MNKD) is 39.57 and the Price/Book (PB) ratio is -38.18.